Justify proposed dose and rationality: CDSCO Panel Tells Lupin on FDC Sacubitril plus Valsartan Dr. Divya Colin29 Jan 2024 6:00 PM ISTNew Delhi: In response to the proposal presented by the drug major Lupin for the fixed-dose combination (FDC) cardiovascular drug Sacubitril plus...
Managing Heart Failure in India with Sacubitril Valsartan: Lessons from Clinical Trials Dr. Prem Aggarwal19 Sept 2022 11:35 AM ISTChronic Heart Failure (CHF) is a complex syndrome in which the heart cannot provide adequate cardiac output to meet the body's metabolic requirements...
Delhi HC restrains 4 pharma firms from making, selling 2 Novartis patent drugs Roshni Dhar10 Nov 2021 12:24 AM ISTIn a major relief to Novartis, the Delhi High Court has restrained various generic pharmaceutical companies from manufacturing or selling Valsartan...
